Low blood pressure sa dialysis: intradialytic at post-dialysis hypotension — causes, prevention at kailan delikado?

Hypotension means blood pressure that is too low for the patient's circulation and symptoms. Sa dialysis, hindi sapat na tingnan ang isang number lang. Mahalaga ang baseline BP, gaano kalaki ang ibinaba, pinakamababang BP habang treatment, symptoms, at kung kinailangang bawasan ang ultrafiltration o magbigay ng fluid.

Iba-iba ang formal definitions ng intradialytic hypotension o IDH. Ang older KDOQI definition ay pagbaba ng systolic BP ng at least 20 mmHg o mean arterial pressure ng at least 10 mmHg na may kasamang symptoms o nangangailangan ng intervention. Sa KDIGO dialysis BP conference report, anumang symptomatic BP decrease o nadir systolic BP below 90 mmHg ay dapat mag-trigger ng reassessment ng BP at volume management.

Hindi ibig sabihin na ang bawat SBP na below 90 ay pare-pareho ang danger level. May patients na chronically low ang BP at may iba namang symptomatic kahit mas mataas pa rito. Clinical context ang mahalaga.

Intradialytic hypotension happens habang tumatakbo ang dialysis. Madalas lumalabas habang dumarami ang fluid na naaalis, pero puwede rin itong mangyari nang maaga dahil sa cardiac problem, autonomic dysfunction, medication effect, pagkain, dialysate reaction, infection o ibang acute cause.

Post-dialysis hypotension naman ay low BP na nagpapatuloy o nagiging symptomatic pagkatapos ng treatment. Puwedeng okay ang BP habang nakahiga sa machine pero manghina o mahilo pag-upo o pagtayo. Sa ganitong situation, maaaring hindi pa nakaka-recover ang effective circulating volume pagkatapos ng ultrafiltration.

Ang post-dialysis dizziness ay hindi automatic na simpleng dehydration. Kung paulit-ulit, severe, o may chest pain, dyspnea, palpitations, fever, bleeding o neurologic symptoms, kailangang isipin ang ibang causes.

Ang pinaka-basic na mechanism ay mismatch sa pagitan ng fluid na inaalis ng ultrafiltration at fluid na kayang ibalik ng tissues papunta sa bloodstream. Habang inaalis ang plasma water, kailangang mag-refill ang intravascular space mula sa interstitial fluid. Kapag mas mabilis ang removal kaysa refill, bababa ang effective circulating volume.

Normal na response ng katawan ang pagtaas ng heart rate, cardiac contractility at vasoconstriction para mapanatili ang BP. Kapag mahina ang cardiac reserve o hindi maayos ang autonomic response, mas madaling bumagsak ang BP kahit hindi sobrang taas ng ultrafiltration rate.

Kaya ang IDH ay hindi lang 'sobrang UF.' Interaction ito ng ultrafiltration rate, plasma refill, cardiac output at vascular tone.

Kapag malaki ang fluid gain sa pagitan ng sessions, mas maraming fluid ang kailangang alisin sa limitadong treatment time. Mas mataas na ultrafiltration rate means mas mabilis na bumababa ang circulating volume, at mas mataas ang chance na hindi makasabay ang plasma refill.

Observational studies consistently associate higher ultrafiltration rates with intradialytic hypotension and worse outcomes. Pero ayon sa KDIGO, hindi tama na gumamit ng isang universal UFR cutoff para sa lahat ng pasyente sa lahat ng sessions. May pasyente na symptomatic kahit relatively modest ang UFR, lalo na kung may diabetes, autonomic dysfunction o heart disease.

Kung sobrang dami ang kailangang alisin, minsan mas ligtas ang longer treatment, additional session, o staged fluid removal kaysa piliting habulin ang target sa maikling session.

Kung mas mababa ang target weight kaysa sa tunay na euvolemic weight, puwedeng piliting alisin ang fluid na hindi na excess. Resulta nito: cramps, nausea, yawning, sweating, dizziness, low BP, near-fainting at prolonged weakness after dialysis.

Target weight can become outdated after hospitalization, infection, poor appetite, muscle loss, surgery, rehabilitation o tunay na weight gain. Kaya mahalaga ang serial pre- at post-dialysis weights, symptoms, BP pattern at physical assessment.

Kapag unclear ang fluid status, objective tools such as bioimpedance spectroscopy or BCM may support the assessment in some centers, but they do not replace clinical judgment.

Heart failure, reduced ejection fraction, diastolic dysfunction, valvular disease, ischemic heart disease at arrhythmias can limit the heart's ability to maintain cardiac output while fluid is being removed.

Minsan ang repeated IDH itself can worsen myocardial perfusion and contribute to myocardial stunning. Kaya kung frequent ang episodes, hindi sapat na paulit-ulit lang magbigay ng saline without reviewing the underlying pattern.

New chest pain, significant arrhythmia, persistent palpitations, severe dyspnea o unexplained recurrent hypotension deserve medical review for cardiac causes.

Ang autonomic nervous system ang tumutulong mag-constrict ng blood vessels at mag-adjust ng heart rate kapag bumababa ang circulating volume. Sa ilang dialysis patients—especially those with long-standing diabetes or autonomic neuropathy—mahina ang compensatory response.

Dahil dito, puwedeng bumagsak ang BP kahit hindi extreme ang fluid removal. Ang pattern na ito ay isa sa dahilan kung bakit hindi puwedeng kopyahin ang UF rate o target weight ng ibang pasyente.

Antihypertensive medicines can contribute to low BP in selected patients, pero hindi tama ang blanket rule na lahat ng BP medicines ay dapat i-skip bago dialysis.

KDIGO recommends individualizing the timing of antihypertensive medication based on interdialytic BP, intradialytic BP pattern, cardiovascular indication at drug dialyzability. The benefit of routinely withholding antihypertensives before dialysis to prevent IDH remains uncertain.

Huwag mag-hold ng BP medicine nang sarili. Ang safest approach ay ipakita sa nephrologist ang pre-, intra- at post-dialysis BP trends at itanong kung may gamot, dose o timing na kailangang i-review.

Pagkatapos kumain, mas maraming blood flow ang napupunta sa gastrointestinal circulation. Sa susceptible patients, puwedeng bumaba ang vascular resistance at BP habang sabay na nag-aalis ng fluid ang dialysis.

Kaya some dialysis programs avoid or limit meals during treatment in patients with recurrent IDH. Pero hindi ito one-size-fits-all dahil kailangan ding protektahan ang nutrition, lalo na sa malnourished patients.

Kung napapansin na paulit-ulit ang hilo o BP drop after eating during dialysis, i-report ang pattern sa dialysis team kaysa basta mag-fasting on your own.

Dialysate temperature can affect vascular tone. Cooler dialysate is one of the better-supported non-drug strategies for recurrent IDH because it can reduce heat-related vasodilation and improve hemodynamic stability. Some patients, however, feel uncomfortably cold, so it should be individualized.

Dialysate sodium and calcium can also influence BP and vascular stability. Higher dialysate sodium or sodium profiling may reduce some hypotensive episodes but can increase thirst, sodium loading and interdialytic weight gain, so routine use is not appropriate for everyone.

These settings are part of the dialysis prescription. Patients should not ask for arbitrary changes based only on one bad session.

Hindi lahat ng severe hypotension during dialysis ay galing sa fluid removal. Acute infection or sepsis, bleeding, myocardial infarction, significant arrhythmia, allergic or dialyzer reaction, air embolism, hemolysis and other medical emergencies can also cause sudden instability.

Kung unusually severe ang episode, very early sa session, hindi tugma sa usual UF pattern, o may fever, chills, chest pain, severe dyspnea, back pain, confusion, bleeding or access problem, kailangan ng immediate clinical evaluation.

Repeated low BP outside dialysis also deserves review. Chronic hypotension may reflect cardiac disease, autonomic dysfunction, medication effects, poor nutrition or another systemic problem.

Immediate management depends on severity and symptoms. Common clinical measures include reducing or temporarily stopping ultrafiltration, positioning the patient appropriately, checking the machine and access, reassessing BP, and giving isotonic saline or another intervention when indicated by the unit protocol.

Ang mahalagang point para sa patient: sabihin agad kapag may dizziness, nausea, yawning, cramps, cold sweat, blurred vision, weakness, chest discomfort o parang mahihimatay. Huwag hintaying tuluyang mawalan ng malay bago magsabi.

After the episode, the team should look for the cause—not just restore the BP. Frequent IDH should trigger review of UFR, treatment time, IDWG, dry weight, medication timing, cardiac status and dialysis prescription.

Prevention is usually multi-factorial. The best strategy depends on why the BP is dropping. Non-drug approaches are generally prioritized before adding BP-raising medicines.

A practical prevention plan can include keeping interdialytic fluid gain within the individualized goal, reducing dietary sodium to control thirst, reassessing dry weight, lowering the required UFR, extending treatment time or frequency when needed, using cooler dialysate in selected patients, reviewing meals during dialysis, and reviewing medications with the nephrologist.

Adequate dialysis time matters. Avoiding hypotension should not mean routinely ending treatments early and leaving the patient chronically fluid overloaded or underdialyzed.

Midodrine is an oral vasoconstrictor sometimes used before dialysis in patients with recurrent symptomatic IDH despite non-drug measures. It can raise BP in some patients, but evidence is based largely on small or short studies and it is not appropriate for everyone.

KDIGO notes that other agents have also been studied, but overall evidence for BP-raising medicines in IDH is weak. Cardiovascular assessment, UFR minimization and target-weight reassessment should be prioritized.

Do not borrow midodrine or take it because another dialysis patient uses it. It can cause supine hypertension and may be unsafe in some cardiovascular conditions.

After dialysis, circulation may need time to equilibrate after fluid removal. Some patients feel okay while lying down but become dizzy when sitting or standing. This may reflect low effective circulating volume and orthostatic intolerance.

Sa dialysis unit, sabihin muna sa staff bago tumayo kung mahina o nahihilo. Dahan-dahang umupo, maghintay, then stand with assistance if needed. Falls after dialysis can cause serious injury.

Do not automatically drink large amounts of fluid to 'fix' post-dialysis low BP unless the dialysis team instructs you. Over-correcting with fluid can worsen interdialytic weight gain and make the next session harder.

Persistent low BP hours after dialysis, repeated near-fainting, inability to walk safely, or symptoms that are getting worse should be clinically reviewed rather than accepted as 'normal after dialysis.'

Frequent symptomatic hypotension can reduce dialysis tolerance and may lead to shortened treatments, inadequate dialysis dose and difficulty achieving volume goals.

IDH is also associated with vascular access thrombosis and repeated episodes of reduced perfusion to organs. Research links recurrent IDH with myocardial ischemia or stunning and adverse outcomes, although the exact causal contribution varies across patients.

The goal is not simply to chase a higher BP number; it is to maintain adequate organ perfusion while still achieving safe volume control and adequate dialysis.

A simple pattern log is often more useful than one isolated reading. Record or ask for the pre-dialysis BP, lowest BP during treatment, post-dialysis BP, pre/post weight, target weight, UF goal, timing of symptoms and whether the episode happened after eating or after taking a particular medicine.

If available, note whether the episodes happen mainly on the first session after the long dialysis gap, when interdialytic weight gain is higher, or only when trying to reach a particular target weight.

Call the dialysis staff immediately during treatment for severe dizziness, inability to stay awake, fainting, chest pain, severe shortness of breath, new confusion, one-sided weakness, new severe palpitations or signs of significant bleeding.

After dialysis, urgent assessment is appropriate if low BP is accompanied by fainting, chest pain, severe dyspnea, persistent confusion, new neurologic deficit, uncontrolled bleeding, fever/chills with suspected infection, or symptoms that do not improve with the dialysis team's usual measures.

A recurrent but milder BP drop still deserves review if it repeatedly prevents completion of dialysis, requires saline every session, causes falls, or leaves the patient severely weak for hours.

Intradialytic and post-dialysis hypotension are common but should not simply be accepted as an unavoidable part of dialysis. The cause can be excessive or rapid fluid removal, inaccurate target weight, poor vascular compensation, heart disease, autonomic dysfunction, medication timing, meals, dialysate factors or an acute illness.

The safest approach is pattern-based: review BP and weight trends, UFR, treatment time, symptoms, dry weight and medicines with the dialysis team. Prevention often means improving fluid and sodium control, reducing the required UFR, reassessing target weight and individualizing the dialysis prescription—not simply giving saline repeatedly or stopping dialysis early.

Do not self-adjust ultrafiltration, dry weight, BP medicines, dialysate settings or BP-raising medicines based on another patient's experience.